BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23678173)

  • 1. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.
    Kati S; Tsao EH; Günther T; Weidner-Glunde M; Rothämel T; Grundhoff A; Kellam P; Schulz TF
    J Virol; 2013 Jul; 87(14):8004-16. PubMed ID: 23678173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.
    Chen L; Lagunoff M
    J Virol; 2005 Nov; 79(22):14383-91. PubMed ID: 16254372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.
    Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA
    J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes.
    Cheng B; Martínez FP; Katano H; Tang Q
    J Clin Virol; 2009 Nov; 46(3):244-8. PubMed ID: 19726225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
    Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
    J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus.
    Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF
    J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor signaling controls reactivation of KSHV from latency.
    Gregory SM; West JA; Dillon PJ; Hilscher C; Dittmer DP; Damania B
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11725-30. PubMed ID: 19564611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus.
    Großkopf AK; Schlagowski S; Hörnich BF; Fricke T; Desrosiers RC; Hahn AS
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions.
    Dalton-Griffin L; Wilson SJ; Kellam P
    J Virol; 2009 Jul; 83(14):7202-9. PubMed ID: 19403667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
    PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
    Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1.
    Matar CG; Rangaswamy US; Wakeman BS; Iwakoshi N; Speck SH
    J Virol; 2014 Oct; 88(19):11600-10. PubMed ID: 25078688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
    Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
    Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
    J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
    Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
    Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
    Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.